Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The general cellular thiol and reactive oxygen species (ROS) pool refers to the dynamic equilibrium between oxidizing agents and antioxidant molecules within a cell. This system is primarily composed of low-molecular-weight thiols, most notably glutathione (GSH), and enzymatic systems like thioredoxin and glutaredoxin that manage the levels of ROS such as superoxide, hydrogen peroxide, and hydroxyl radicals (PubMed: 28216064). Biologically, this pool is essential for maintaining the proper folding of proteins, protecting DNA from oxidative damage, and acting as a secondary messenger in various signal transduction pathways (NIH: PMC4284551). In many diseases, such as cancer and neurodegeneration, this balance is disrupted; cancer cells often maintain high thiol levels to survive increased metabolic stress, while neurodegenerative conditions are characterized by a depleted antioxidant capacity (StatPearls: NBK545213). Pharmacological intervention targets this pool either by providing precursors to boost antioxidant defenses, such as N-acetylcysteine, or by using pro-oxidants to overwhelm the defense mechanisms of diseased cells (PubChem: CID 12035). Consequently, the cellular thiol/ROS pool serves as a critical, albeit broad, therapeutic landscape for modulating cell survival and death.
Modulation of the cellular redox state through the direct scavenging of reactive species, inhibition of antioxidant enzymes like thioredoxin reductase, or replenishment of thiol-containing molecules to restore homeostasis or induce oxidative-stress-mediated cell death (PubMed: 28216064, PubChem: CID 12035).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on General cellular thiol and reactive oxygen species pool (ROS/Thiol pool).